Skip Nav Destination
Issues
1 February 2009
-
Cover Image
Cover Image
Confocal laser scanning microscopy (CLSM) staining with mAb16D10 in frozen (upper panels) and formalin-fixed, paraffin-embedded (lower panels) sections of pancreatic ductal adenocarcinoma. In pancreatic ductal adenocarcinoma, a strong staining is found in plasma membrane and in cytoplasm. Images stained with mAb16D10 were counterstained with Mayer's hematoxylin before CLSM observation. Original magnification 300×. For details, see Benkoël et al., in this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1535-7163
EISSN 1538-8514
Minireview
Research Articles: Therapeutics, Targets, and Development
Monoclonal antibody 16D10 to the COOH-terminal domain of the feto-acinar pancreatic protein targets pancreatic neoplastic tissues
Liliane Benkoël; Jean-Paul Bernard; Marie-José Payan-Defais; Lydie Crescence; Cécile Franceschi; Mireille Delmas; Mehdi Ouaissi; Bernard Sastre; José Sahel; Anne-Marie Benoliel; Pierre Bongrand; Françoise Silvy; Laurent Gauthier; François Romagné; Dominique Lombardo; Eric Mas
A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development
Antonio Jimeno; Georg Feldmann; Ana Suárez-Gauthier; Zeshaan Rasheed; Anna Solomon; Gang-Ming Zou; Belen Rubio-Viqueira; Elena García-García; Fernando López-Ríos; William Matsui; Anirban Maitra; Manuel Hidalgo
Inhibition of cervical cancer cell growth by human papillomavirus virus–like particles packaged with human papillomavirus oncoprotein short hairpin RNAs
Latifa Bousarghin; Antoine Touze; Guillaume Gaud; Sophie Iochmann; Eva Alvarez; Pascale Reverdiau; Julien Gaitan; Marie-Lise Jourdan; Pierre-Yves Sizaret; Pierre L. Coursaget
Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines
Michelle J. Clarke; Evan A. Mulligan; Patrick T. Grogan; Ann C. Mladek; Brett L. Carlson; Mark A. Schroeder; Nicola J. Curtin; Zhenkun Lou; Paul A. Decker; Wenting Wu; E. Ruth Plummer; Jann N. Sarkaria
Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors
Claudia Forni; Mario Minuzzo; Emanuela Virdis; Elena Tamborini; Matteo Simone; Michele Tavecchio; Eugenio Erba; Federica Grosso; Alessandro Gronchi; Pierre Aman; Paolo Casali; Maurizio D'Incalci; Silvana Pilotti; Roberto Mantovani
WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells
Yaxiong Tang; Anne R. Simoneau; Wu-xiang Liao; Guo Yi; Christopher Hope; Feng Liu; Shunqiang Li; Jun Xie; Randall F. Holcombe; Frances A. Jurnak; Dan Mercola; Bang H. Hoang; Xiaolin Zi
Corrections
Advertisement
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds